Stopfer JE - Search Results

1

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.

Domchek SM, Jhaveri K, Patil S, Stopfer JE, Hudis C, Powers J, Stadler Z, Goldstein L, Kauff N, Khasraw M, Offit K, Nathanson KL, Robson M. Domchek SM, et al. Among authors: stopfer je. Cancer. 2013 Apr 1;119(7):1344-8. doi: 10.1002/cncr.27842. Epub 2012 Nov 16. Cancer. 2013. PMID: 23165893 Free article.

2

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL. Hoskins KF, et al. Among authors: stopfer je. JAMA. 1995 Feb 15;273(7):577-85. JAMA. 1995. PMID: 7837392

3

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. Couch FJ, et al. N Engl J Med. 1997 May 15;336(20):1409-15. doi: 10.1056/NEJM199705153362002. N Engl J Med. 1997. PMID: 9145677 Free article.

4

Establishing a cancer risk evaluation program.

Calzone KA, Stopfer J, Blackwood A, Weber BL. Calzone KA, et al. Cancer Pract. 1997 Jul-Aug;5(4):228-33. Cancer Pract. 1997. PMID: 9250079

5

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Armstrong K, et al. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097234

6

BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.

Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. Shih HA, et al. J Clin Oncol. 2002 Feb 15;20(4):994-9. doi: 10.1200/JCO.2002.20.4.994. J Clin Oncol. 2002. PMID: 11844822

7

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations.

Armstrong K, Stopfer J, Calzone K, Fitzgerald G, Coyne J, Weber B. Armstrong K, et al. Genet Test. 2002 Summer;6(2):115-8. doi: 10.1089/10906570260199366. Genet Test. 2002. PMID: 12215250

8

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Brose MS, et al. Among authors: stopfer je. J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72. doi: 10.1093/jnci/94.18.1365. J Natl Cancer Inst. 2002. PMID: 12237282

9

Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk.

Armstrong K, Weber B, Stopfer J, Calzone K, Putt M, Coyne J, Schwartz JS. Armstrong K, et al. Am J Med Genet A. 2003 Mar 1;117A(2):154-60. doi: 10.1002/ajmg.a.10928. Am J Med Genet A. 2003. PMID: 12567413

10

Application of breast cancer risk prediction models in clinical practice.

Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Domchek SM, et al. J Clin Oncol. 2003 Feb 15;21(4):593-601. doi: 10.1200/JCO.2003.07.007. J Clin Oncol. 2003. PMID: 12586794 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters